financetom
Business
financetom
/
Business
/
Update: Amaroq Minerals Falls 4% as Launches Single Mine Origin Gold Sales from Greenland Mine
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Amaroq Minerals Falls 4% as Launches Single Mine Origin Gold Sales from Greenland Mine
Oct 17, 2025 8:49 AM

11:29 AM EDT, 10/17/2025 (MT Newswires) -- Amaroq Minerals (AMRQ.V) said Friday that it launched single mine origin (SMO) gold sales from its Nalunaq mine in Greenland following the company's successful integration into the SMO platform.

According to Amaroq ( AMRQF ), all SMO gold is fully traceable from mine site to end customer and produced in accordance with internationally recognized responsibility standards.

"This initiative reflects our deep commitment to transparency, ethical mining and collaboration with local communities," Amaroq ( AMRQF ) chief operating officer Joan Plant said. "Through the SMO platform, we are setting a new standard for sustainability and community partnership in the region."

Amaroq's ( AMRQF ) share price at last look fell 4% to $1.77 Friday on the TSX Venture Exchange.

Price: 1.77, Change: -0.08, Percent Change: -4.32

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Takeda Pharmaceutical Receives FDA Approval for Single-Dose Injection Crohn's Disease Treatment
Takeda Pharmaceutical Receives FDA Approval for Single-Dose Injection Crohn's Disease Treatment
Apr 19, 2024
04:13 AM EDT, 04/19/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) said Thursday it received US Food and Drug Administration approval for subcutaneous injection of Entyvio as a maintenance therapy in adults with moderately to severely active Crohn's disease following induction therapy with intravenous Entyvio. The approval followed a 409-patient phase 3 trial of Entyvio in which 48% of...
Tungray Technologies Prices IPO at $4 a Share
Tungray Technologies Prices IPO at $4 a Share
Apr 19, 2024
04:04 AM EDT, 04/19/2024 (MT Newswires) -- Tungray Technologies said late Thursday it priced its initial public offering of approximately 1.3 million class A ordinary shares at $4 per share for expected gross proceeds of about $5 million. The underwriters have been granted a 45-day option to purchase up to 187,500 additional shares. Closing of the offering is expected to...
Lufthansa seeks to persuade EU regulators over ITA stake buy
Lufthansa seeks to persuade EU regulators over ITA stake buy
Apr 19, 2024
BRUSSELS (Reuters) - Lufthansa executives and lawyers will attend a day-long hearing in Brussels on Friday to try to convince EU antitrust regulators to clear the company's bid for a minority stake in Italian rival ITA Airways. Lufthansa last week submitted remedies to address the EU competition watchdog's concerns about its 325-million-euro ($346 million) bid for a 41% stake in...
NeoGames Heads Toward Closing Aristocrat Leisure Acquisition Next Week
NeoGames Heads Toward Closing Aristocrat Leisure Acquisition Next Week
Apr 19, 2024
04:25 AM EDT, 04/19/2024 (MT Newswires) -- NeoGames ( NGMS ) confirmed late Thursday that all necessary regulatory approvals required to complete its merger with Aristocrat Leisure have been received or waived. The company also said it has received all antitrust and foreign investment regulatory clearances. The move marks a further step toward completion of the acquisition before the final...
Copyright 2023-2026 - www.financetom.com All Rights Reserved